ARCHIVES

Opdivo Study Shows 41 Percent One-Year Survival In Patients With at Least Two Past Therapies

This article is from The Cancer Letter archive.

Vol. 37 No. 11 | November 28, 2014

Download PDF Visit The Full Archive

Related Articles

Funding Opportunities

January 17, 2003

NCAB Delays Approval Of New Comprehensive Center Guidelines

October 12, 1979

NIH Modifies IRG voting Procedure In Success Rate Switch

August 30, 1991

Consensus Conference In Early Breast Cancer Planned For June

May 11, 1990

Morale, Money Woes Hit MD Anderson

January 18, 2013

Adverse Events Of Chemo More Common Than Expected

August 25, 2006